StockData

Phibro Animal Health vs Zoetis

PAHC and ZTS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PAHC and ZTS compare

Zoetis is the larger company, worth 24 times as much as Phibro Animal Health ($34.5B against $1.4B).

On earnings, Zoetis is cheaper: it trades at 13.7× trailing earnings, against 14.4× for Phibro Animal Health.

Phibro Animal Health grew revenue faster over the last twelve months (17.1% versus 1.5% for Zoetis).

Zoetis keeps more of each dollar of sales as profit, with a net margin of 27.5% compared with 6.6% at Phibro Animal Health.

Both pay dividends: Phibro Animal Health yields 1.4% and Zoetis 1.9%.

Phibro Animal Health scores higher on the StockData Score (22 against 17 for Zoetis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPAHCZTS
Size and price
Market cap$1.4B$34.5B
Share price$34.92$83.48
Change, 1 year−22.6%−30.9%
Change, 5 years67.2%−61.9%
Beta (5Y)−0.070.06
Employees2,60515K
StockData Score
Total score22 (better)17
Valuation score55
Growth score6 (better)2
Performance score6 (better)5
Health score23 (better)
Dividend score3 (better)2
Valuation
P/E14.4×13.7× (better)
P/S0.9× (better)3.6×
P/B3.7× (better)11.0×
EV/EBITDA5.4× (better)10.5×
P/FCF144×14.9× (better)
PEG0.32 (better)1.34
FCF yield0.70%6.7% (better)
Fair value$65.12$154.11
Margin of safety46.4% (better)45.8%
Growth
Revenue growth (TTM)17.1% (better)1.5%
Revenue growth, 5Y average12.7% (better)7.2%
Net income growth (TTM)107% (better)0.96%
EPS growth (TTM)104% (better)5.6%
EPS growth, 5Y average12.6% (better)12.0%
Profitability
Gross margin33.8%71.5% (better)
Operating margin12.8%–
Net margin6.6%27.5% (better)
FCF margin0.65%24.3% (better)
Return on equity29.7%64.4% (better)
Return on invested capital24.7%–
Financial health
Debt / equity–2.87
Net debt / EBITDA–1.85
Interest coverage4.2×–
Current ratio2.963.08 (better)
Altman Z-score3.024.07 (better)
Piotroski F-score68 (better)
Dividends and buybacks
Dividend yield1.4%1.9% (better)
Payout ratio19.5%–
Years of dividend growth013 (better)
Dividend growth, 5Y average0.00%19.0% (better)
Buyback yield–10.6%
Shareholder yield1.4%12.5% (better)
Ownership
Held by institutions51.8%96.1%
Held by insiders98.9%0.08%
Insider net buying, 12 months−$23.0M−$1.7M (better)
Superinvestors holding–3
Short interest, % of float233%4.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.